Loneliness and Mental Health Disorders in Older Adults Living in Portugal During the COVID-19 Pandemic: A Cross-Sectional Study.

Publication date: Jun 20, 2025

Background/Objectives: The COVID-19 pandemic has had a profound impact on the mental health of the general population, particularly older adults. This study aimed to explore the association between loneliness and mental health disorders in this demographic during the pandemic. Methods: A cross-sectional survey was conducted in Portugal using data from the Survey of Health, Ageing and Retirement in Europe (SHARE) database between June and August 2020, during the COVID-19 pandemic (Wave 8 COVID-19 Survey), using computer-assisted telephone interviews. Results: The final sample included 836 participants, with 387 (46. 4%) men and a mean age of 74. 5 years (SD = 6. 7). Mental health indicators revealed that 441 (52. 1%) reported feelings of nervousness, 384 (45. 3%) experienced sadness or depression, 349 (41. 2%) encountered sleeping difficulties, and 280 (33. 1%) reported experiencing loneliness often or some of the time. Increased feelings of loneliness were notably associated with women in poorer health, those with heightened fear of falling, dizziness, fatigue, anxiety, depression, and concurrent health and sleep issues. Age and medication use did not significantly impact feelings of loneliness. Conclusions: The findings highlight a potential association between adverse mental health outcomes among older adults during the initial phase of the pandemic. Future research, employing longitudinal research designs, is warranted to explore these relationships more rigorously, in a post-pandemic context, and to inform effective intervention development and strategies to prevent mental health problems within this vulnerable population.

Open Access PDF

Concepts Keywords
Basel anxiety
Interviews depression
June loneliness
Pandemic mental health
Sleeping older people
pandemic
sleep disorder

Semantics

Type Source Name
disease MESH Loneliness
disease MESH COVID-19 Pandemic
disease MESH Retirement
disease MESH nervousness
disease MESH depression
disease IDO intervention
disease MESH Mental Disorders
drug DRUGBANK Coenzyme M
disease MESH sleep disorder
disease MESH chronic diseases
disease MESH cognitive decline
disease MESH psychological well being
disease MESH morbidity
disease MESH premature mortality
disease MESH anxiety disorders
disease MESH frailty
disease MESH dementia
disease MESH chronic fatigue syndrome
disease MESH death

Original Article

(Visited 1 times, 1 visits today)